Accessibility settings

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65118, first published .
Doctors in blue gloves examine a chest X-ray, one pointing, the other holding a tablet.

Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor–Mutated Nonsquamous Non–Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study

Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor–Mutated Nonsquamous Non–Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study

Journals

  1. Jha M, Bhattacharya S, Gupta G, Sangave P, Beldar V, Sharma S, Saoji S, Singh M. Gefitinib-Loaded Starch/Chitosan Polymeric Nanoparticles for Enhanced Colorectal Cancer Therapy: Network Pharmacology, Molecular Docking, Physicochemical Characterization, and Evaluation in HCT-116 Cells and DMH-Induced Wistar Rats. ACS Nano Medicine 2026 View